<DOC>
	<DOCNO>NCT01077193</DOCNO>
	<brief_summary>Up 45 men woman meet entry criterion undergo gastric plication procedure . The study ass subject excess weight loss ( % EWL ) follow study procedure 1 , 3 , 6 , 12 , 18 , 24 , 30 36 month .</brief_summary>
	<brief_title>Surgical Intervention Bariatric Patients : Excess Weight Loss Morbidly Obese Following Gastric Plication</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>1 . Subject willing give consent comply evaluation treatment schedule ( female patient , include agreement use reliable ( per investigator ) form birth control duration trial ) ; 2 . 18 65 year age ( inclusive ) ; 3 . Subject meet ASMBS NIH criterion : ( consensus.nih.gov ) BMI ³ 40 kg/m2 £ 50 kg/m2 ; , BMI 3540 kg/m2 one significant comorbid medical condition generally expect improve , reverse , resolve weight loss , include : Hyperlipidemia Mild obstructive sleep apnea ( per Investigator discretion ) Hypertension Osteoarthritis hip knee per investigational site 's criterion subject treat ; 4 . ASA Class I III ; 5 . Agree refrain type weightloss drug ( prescription OTC ) elective procedure would affect body weight duration trial ; 6 . HbA1C &lt; 11 % ; 7 . For subject Type 2 diabetes , medication regimen complex ( 2 oral medication ) oral metformin plus one oral sulfonylurea plus daily insulin injection . 1 . Documented history drug and/or alcohol abuse within two ( 2 ) year Screening Visit ; 2 . Previous malabsorptive restrictive procedure perform treatment obesity ; 3 . Scheduled concurrent surgical procedure , exception SOC liver biopsy ; 4 . Women childbearing potential pregnant lactating time screen time surgery ; 5 . Psychiatric disorder may affect compliance clinical trial , include dementia , active psychosis , severe depression require &gt; 2 medication , history suicide attempt ; 6 . Participation investigational device drug study ( nonsurvey base trial ; longterm enrollment study require periodic laboratory test , etc. , would allow ) within 12 week enrollment ; 7 . Any condition precludes compliance study , include : 1 . Inflammatory disease gastrointestinal tract , include severe intractable esophagitis , gastric ulceration , duodenal ulceration , specific inflammation Crohn 's disease ulcerative colitis active within past 10 year ; 2 . Congenital acquire anomaly GI tract , include atresias stenosis ; 3 . Severe cardiopulmonary disease serious organic disease make subject highrisk surgical candidate ; 4 . Uncontrolled hypertension ; 5 . Portal hypertension ; 6 . Chronic acute upper gastrointestinal bleeding condition ( e.g. , gastric esophageal varix ) ; 7 . Cirrhosis ; 8 . Congenital acquire intestinal telangiectasia ; 9 . Esophageal gastric disorder include moderate severe preoperative reflux , dysmotility , Barrett 's esophagus ; 10 . Presence hiatal hernia great 2cm length , exception small sliding hiatal hernia previously undiagnosed discover surgical procedure ; 11 . Prior surgery foregut include hiatal hernia repair prior gastric surgery ; 12 . Known history clot disorder , hemoglobinopathy , hemolytic disorder , include pulmonary embolus Deep Vein Thrombosis ; 13 . Pancreatitis ; 14 . Gallstones ( confirm via ultrasound ) ; 15 . Immunocompromised result chronic oral steroid use , chemotherapeutic agent , immune deficiency disorder ; 16 . Use thiazolidinediones ( `` glitazones '' ) , 17 . Conditions , opinion investigator , may jeopardize subject 's wellbeing and/or soundness clinical study ; 8 . History presence preexist autoimmune connective tissue disease ; 9 . Use prescription counter weight reduction medication supplement within thirty day Screening Visit duration study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Bariatric</keyword>
	<keyword>Obesity</keyword>
</DOC>